• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与更昔洛韦治疗相关的癫痫发作。

Seizures associated with ganciclovir therapy.

作者信息

Barton T L, Roush M K, Dever L L

机构信息

Department of Pharmacology, University of Texas Health Science Center, San Antonio 78284-7766.

出版信息

Pharmacotherapy. 1992;12(5):413-5.

PMID:1331995
Abstract

A 32-year-old man diagnosed with acquired immunodeficiency syndrome and a disseminated cytomegalovirus infection experienced seizures associated with the administration of ganciclovir. Seizures began 1 month after initiation of therapy and worsened with increasing dosages. Despite phenytoin administration, the seizure-like activity subsided only after discontinuing ganciclovir. After rechallenge with ganciclovir the seizures recurred. Although this case was confounded by numerous patient and disease factors, the Naranjo algorithm produced a score of 7, indicating a probable association between ganciclovir and seizure activity.

摘要

一名32岁男性被诊断为获得性免疫缺陷综合征并伴有播散性巨细胞病毒感染,在使用更昔洛韦治疗时出现了癫痫发作。癫痫发作始于治疗开始后1个月,并随着剂量增加而加重。尽管使用了苯妥英钠,但只有在停用更昔洛韦后癫痫样活动才消退。再次使用更昔洛韦后癫痫复发。虽然该病例受到众多患者和疾病因素的干扰,但Naranjo算法得出的评分为7分,表明更昔洛韦与癫痫活动之间可能存在关联。

相似文献

1
Seizures associated with ganciclovir therapy.与更昔洛韦治疗相关的癫痫发作。
Pharmacotherapy. 1992;12(5):413-5.
2
Ganciclovir therapy for opportunistic cytomegalovirus disease in AIDS.
AIDS Clin Rev. 1990:149-63.
3
[Treatment with intravitreous ganciclovir in cytomegalovirus retinitis associated with AIDS].[玻璃体内注射更昔洛韦治疗艾滋病相关巨细胞病毒性视网膜炎]
Enferm Infecc Microbiol Clin. 1992 Dec;10(10):629-30.
4
CMV retinitis treated with ganciclovir [9(1,3-dihydroxy-2-propoxymethyl) guanine] in patients with AIDS.用更昔洛韦[9-(1,3-二羟基-2-丙氧甲基)鸟嘌呤]治疗艾滋病患者的巨细胞病毒性视网膜炎。
Ann Ophthalmol. 1987 Oct;19(10):369-73,375.
5
Oral ganciclovir approved.口服更昔洛韦已获批准。
AIDS Treat News. 1995 Jan 6(No 214):1.
6
Intravitreal ganciclovir for cytomegalovirus retinitis in AIDS patients.玻璃体内注射更昔洛韦治疗艾滋病患者的巨细胞病毒性视网膜炎
Ann Pharmacother. 1992 Jan;26(1):36-7.
7
Treatment of cytomegalovirus infection in the AIDS patient.
Transplant Proc. 1991 Jun;23(3 Suppl 3):122-5.
8
Drug delivery system for AIDS-related disease prevents blindness.
J Ophthalmic Nurs Technol. 1992 May-Jun;11(3):131.
9
Cytomegalovirus retinitis in an infant with acquired immunodeficiency syndrome.一名患有获得性免疫缺陷综合征的婴儿的巨细胞病毒性视网膜炎。
Pediatrics. 1989 Oct;84(4):683-7.
10
Ganciclovir in the treatment of CMV infections in patients with AIDS.
Proc West Pharmacol Soc. 1991;34:323-7.

引用本文的文献

1
A Review of the Association between Infections, Seizures, and Drugs.感染、癫痫发作与药物之间关联的综述
Cent Nerv Syst Agents Med Chem. 2025;25(1):49-55. doi: 10.2174/0118715249288932240416071636.
2
Human Immunodeficiency Viral Infection and Status Epilepticus in United States (2002-2009).美国的人类免疫缺陷病毒感染与癫痫持续状态(2002 - 2009年)
J Vasc Interv Neurol. 2015 Jul;8(3):56-61.
3
Clinical features of seizures in patients with human immunodeficiency virus infection.人类免疫缺陷病毒感染患者癫痫发作的临床特征
J Korean Med Sci. 2015 Jun;30(6):694-9. doi: 10.3346/jkms.2015.30.6.694. Epub 2015 May 13.
4
Valganciclovir in adult solid organ transplant recipients: pharmacokinetic and pharmacodynamic characteristics and clinical interpretation of plasma concentration measurements.伐昔洛韦在成人实体器官移植受者中的应用:药代动力学和药效学特征及血药浓度测定的临床解读。
Clin Pharmacokinet. 2009;48(6):399-418. doi: 10.2165/00003088-200948060-00006.
5
Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement.人类免疫缺陷病毒感染合并中枢神经系统受累时抗逆转录病毒疗法的调整
J Neurovirol. 2008 Jan;14(1):78-84. doi: 10.1080/13550280701793940.
6
Ganciclovir. An update of its therapeutic use in cytomegalovirus infection.更昔洛韦。其在巨细胞病毒感染中治疗应用的最新情况。
Drugs. 1994 Sep;48(3):455-84. doi: 10.2165/00003495-199448030-00009.